Search bioRxiv⌕ Search

Biology subjects

Fiorenza, M. T.

Publications and source records attributed to Fiorenza, M. T..

2 recordsLinked to original sources

Individual differences in learning and decision-making: the role of COMT Val158Met polymorphism in transitive inference

Understanding the ordinal relationships between items requires constructing a rank order supporting decision-making between options. This process depends on the ability to learn reciprocal relationships and to select the best option available when making a choice. In such forms of decision-making, the prefrontal cortex (PFC) plays a crucial role in encoding the relative value of alternatives as a decision is formed. Higher-order cognitive abilities are influenced by genetic factors that affect dopamine availability in the PFC, potentially contributing to individual differences. Here, we examined the performance of 83 participants in a transitive inference task (TI), grouped by genotype based on the Val158Met single-nucleotide polymorphism in the Catechol-O-Methyltransferase (COMT) gene. The task included a learning phase in which participants acquired the reciprocal relationships among a set of hierarchically ranked items (A>B>C>D>E>F), followed by a test phase in which they were required to compare all possible item pairs and select the higher-ranked one. While genotype did not significantly influence test-phase performance, it did affect learning efficiency. Specifically, Val homozygotes took a longer learning procedure than both heterozygotes and Met homozygotes during the learning phase. Drift diffusion modelling (DDM) revealed that task performance was explained by the efficiency of evidence accumulation, which was lower in Val homozygotes, accounting for their poorer performance not only during initial learning but also when required to switch to a reversed hierarchical structure (A<B<C<D<E<F). These findings suggest that individual differences in inferential decision-making and cognitive flexibility may be partially driven by genetically determined variations in prefrontal dopamine availability.

neuroscience↗

Inactivation of the Niemann Pick C1 cholesterol transporter 1 (NPC1) restricts SARS-CoV-2 infection

The Niemann Pick C1 (NPC1) protein is an intracellular cholesterol transporter located in the late endosome/lysosome (LE/Ly) and is involved in cholesterol mobilization. Loss-of-function mutations of the NPC1 gene lead to accumulation of cholesterol and sphingolipids in LE/Ly, resulting in severe fatal NPC1 disease. Cellular alterations associated with NPC1 inactivation affect both the integrity of lipid rafts and the endocytic pathway. Because the angiotensin-converting enzyme 2 (ACE2) and type 2 serine transmembrane protease (TMPRSS2) of the SARS-CoV-2 Spike (S) protein also localize to lipid rafts, we sought to investigate the hypothesis that NPC1 inactivation would generate an intrinsically unfavorable barrier to SARS-CoV-2 entry. In this study, we demonstrate that NPC1 pharmacological inactivation or CRISP/R-Cas mediated ablation of NPC1 dramatically reduced SARS-CoV-2 infectivity. More specifically, our findings demonstrate that pharmacological inactivation of NPC1 results in massive accumulation of ACE2 in the autophagosomal/lysosomal compartment. A >40-fold decrease in virus titer indicates that this effectively prevents VSV-Spike-GFP infection by impeding virus binding and entry. A similarly marked decrease in viral infectivity is observed in cells that had NPC1 expression genetically abrogated. These observations were further confirmed in a de novo SARS-CoV-2 infection paradigm, where cells were infected with the naturally pathogenic SARS-CoV-2. Overall, this work offers strong evidence that NPC1 function is essential for successful SARS-CoV-2 infection, thus implicating NPC1 as a potential therapeutic target in COVID-19 management. SignificanceA significant convergence exists between the cellular alterations associated with NPC1 inactivation and the mechanistic processes of SARS-CoV-2 infectivity. These alterations affect the integrity of lipid-enriched plasma membrane microdomains and the endocytic pathway. Furthermore, the cholesterol-regulated ACE2 receptor protein that facilitates SARS-Cov-2 viral binding and entry is targeted to the autophagolysosomal compartment upon NPC1 inactivation, thus hindering virus-host cell interaction. To our knowledge, this study provides the first evidence that NPC1 function represents a crucial factor for SARS-CoV-2 infection and suggests therapeutic opportunities.

cell biology↗